These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23356330)

  • 1. Fovea and foveation in Parkinson's disease.
    Bodis-Wollner I; Glazman S; Yerram S
    Behav Neurosci; 2013 Apr; 127(2):139-50. PubMed ID: 23356330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foveal vision is impaired in Parkinson's disease.
    Bodis-Wollner I
    Parkinsonism Relat Disord; 2013 Jan; 19(1):1-14. PubMed ID: 22998939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Line bisection in Parkinson's disease: investigation of contributions of visual field, retinal vision, and scanning patterns to visuospatial function.
    Laudate TM; Neargarder S; Cronin-Golomb A
    Behav Neurosci; 2013 Apr; 127(2):151-63. PubMed ID: 23356329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific impairment of visual spatial covert attention mechanisms in Parkinson's disease.
    Sampaio J; Bobrowicz-Campos E; André R; Almeida I; Faria P; Januário C; Freire A; Castelo-Branco M
    Neuropsychologia; 2011 Jan; 49(1):34-42. PubMed ID: 21075128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography in Parkinson's disease: is the retina a biomarker?
    Lee JY; Ahn J; Kim TW; Jeon BS
    J Parkinsons Dis; 2014; 4(2):197-204. PubMed ID: 24518436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
    Silva MF; Faria P; Regateiro FS; Forjaz V; Januário C; Freire A; Castelo-Branco M
    Brain; 2005 Oct; 128(Pt 10):2260-71. PubMed ID: 16000338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visuo-cognitive dysfunctions in Parkinson's disease.
    Antal A; Bandini F; Kéri S; Bodis-Wollner I
    Clin Neurosci; 1998; 5(2):147-52. PubMed ID: 10785841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Don't look now or look away: two sources of saccadic disinhibition in Parkinson's disease?
    van Stockum S; MacAskill M; Anderson T; Dalrymple-Alford J
    Neuropsychologia; 2008 Nov; 46(13):3108-15. PubMed ID: 18674551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Visuoperceptual processing in Parkinson's disease: from the retina to the frontal cortex].
    Ruiz-Sánchez de León JM; Fernández-Guinea S
    Rev Neurol; 2005 May 1-15; 40(9):557-62. PubMed ID: 15898018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinopathy in Parkinson Disease.
    Bodis-Wollner I
    J Neural Transm (Vienna); 2009 Nov; 116(11):1493-501. PubMed ID: 19730784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attentional and perceptual impairments in Parkinson's disease with visual hallucinations.
    Koerts J; Borg MA; Meppelink AM; Leenders KL; van Beilen M; van Laar T
    Parkinsonism Relat Disord; 2010 May; 16(4):270-4. PubMed ID: 20153970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficits in saccadic eye-movement control in Parkinson's disease.
    Chan F; Armstrong IT; Pari G; Riopelle RJ; Munoz DP
    Neuropsychologia; 2005; 43(5):784-96. PubMed ID: 15721191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intrinsically restructured fovea is correlated with contrast sensitivity loss in Parkinson's disease.
    Pinkhardt EH; Ding Y; Slotnick S; Kassubek J; Ludolph AC; Glazman S; Selesnick I; Bodis-Wollner I
    J Neural Transm (Vienna); 2020 Sep; 127(9):1275-1283. PubMed ID: 32676747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response times for visually guided saccades in persons with Parkinson's disease: a meta-analytic review.
    Chambers JM; Prescott TJ
    Neuropsychologia; 2010 Mar; 48(4):887-99. PubMed ID: 19913042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating visual misperceptions in Parkinson's disease: a novel behavioral paradigm.
    Shine JM; Halliday GH; Carlos M; Naismith SL; Lewis SJ
    Mov Disord; 2012 Apr; 27(4):500-5. PubMed ID: 22488861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal psychophysical visual perception in Parkinson's disease patients.
    Crevits L
    Acta Neurol Belg; 2003 Jun; 103(2):83-7. PubMed ID: 12892001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention and visual dysfunction in Parkinson's disease.
    Botha H; Carr J
    Parkinsonism Relat Disord; 2012 Jul; 18(6):742-7. PubMed ID: 22503538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations.
    Bertrand JA; Bedetti C; Postuma RB; Monchi O; Génier Marchand D; Jubault T; Gagnon JF
    Mov Disord; 2012 Dec; 27(14):1781-8. PubMed ID: 23147270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the basal ganglia in the control of automatic visuospatial attention.
    Fielding J; Georgiou-Karistianis N; White O
    J Int Neuropsychol Soc; 2006 Sep; 12(5):657-67. PubMed ID: 16961947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual and spatial symptoms in Parkinson's disease.
    Davidsdottir S; Cronin-Golomb A; Lee A
    Vision Res; 2005 May; 45(10):1285-96. PubMed ID: 15733961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.